(Q36842367)

16 August 2017

1 reference

title

Body composition, metabolic syndrome and testosterone in ageing men. (English)

1 reference

16 August 2017

1 reference

1 reference

1 reference

Allan CA

1

1 reference

PubMed ID

17554396

16 August 2017

Strauss BJ

series ordinal

2

1 reference

PubMed ID

17554396

16 August 2017

McLachlan RI

series ordinal

3

1 reference

16 August 2017

7 June 2007

1 reference

International Journal of Impotence Research

16 August 2017

1 reference

16 August 2017

19

1 reference

16 August 2017

5

1 reference

16 August 2017

448-457

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ijir.3901552

16 August 2017

0 references

cites work

Regulation of body composition by androgens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

The Relationship between Muscle Mass and Muscle Strength in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Effects of an oral androgen on muscle and metabolism in older, community-dwelling men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Testosterone administration to older men improves muscle function: molecular and physiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Androgen treatment of abdominally obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Testosterone and regional fat distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Effects of transdermal testosterone on lipids and vascular reactivity in older men with low bioavailable testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Underweight and Overweight in Relation to Mortality Among Men Aged 40-59 and 50-69 Years: The Seven Countries Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

A Population-Level Decline in Serum Testosterone Levels in American Men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Adult lean body mass declines with age: some longitudinal observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Imaging techniques and anatomical body composition in aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Longitudinal changes in body composition in older men and women: role of body weight change and physical activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Longitudinal changes in adult fat-free mass: influence of body weight

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

The five-level model: a new approach to organizing body-composition research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Proof of the effect of testosterone on skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Testosterone dose-response relationships in healthy young men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Treatment with oxandrolone and the durability of effects in older men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Difficulties in measuring the effect of testosterone replacement therapy on muscle function in older men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Effects of androgen therapy on adipose tissue and metabolism in older men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

DHEA in elderly women and DHEA or testosterone in elderly men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Metabolic syndrome: a solution in search of a problem

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Metabolic syndrome: a multiplex cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Endogenous sex hormones and cardiovascular disease in men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Close relation of endothelial function in the human coronary and peripheral circulations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Androgens and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomized, placebo-controlled clinical trial of recombinant human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

The influence of testosterone upon vascular reactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Physiological testosterone replacement and arterial endothelial function in men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Vascular reactivity in hypogonadal men is reduced by androgen substitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Androgens and coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Androgens, insulin resistance and vascular disease in men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901552

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3901552

1 reference

16 August 2017

1 reference

PubMed ID

17554396